Brainwave-Discovery Ltd is developing novel Drosophila models of neurodegeneration to study multiple genetic interactions and variants, in a fast, cost-effective manner and with increased relevance to the human condition. Brainwave-Discovery Ltd is looking to collaborate with a pharmaceutical company to develop and validate the model for target validation and compound screening. This invertebrate model could reduce the requirement for mammalian models yet increase the number of compounds that may be screened. For further information please see the flyer.